. . . . . . . . . "\"TYSABRI is contraindicated in patients who have or have had progressive multifocal leukoencephalopathy (PML) [ see Warnings and Precautions ( 5.1 TYSABRI is contraindicated in patients who have had a hypersensitivity reaction to TYSABRI. Observed reactions range from urticaria to anaphylaxis [ see Warnings and Precautions ( 5.5 Patients who have or have had PML ( 4 Patients who have had a hypersensitivity reaction to TYSABRI ( 4 5.3\"" . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "R4T2SEtGuVb24myLUO3eSALoW54ZfhlDIARy2faNb7byEPwjVxLmtUz3FVQu2lfxayBscE337dyU1ci/YQDezmKn6NhUjNhieSwijGg/QTWOOvKu6ZSC9X65GyvnTu6W1VDdY0as+GnKgH7GbibR9qWWYaCy6GRnaOnbbPOrHCw=" . . "2021-08-23T18:31:53.513+02:00"^^ . . . . .